Evidence map›Paper›PMID 37945590›Full record

ArticleScientific reports2023

Multimodal graph attention network for COVID-19 outcome prediction.

Matthias Keicher, Hendrik Burwinkel, David Bani-Harouni, Magdalini Paschali, Tobias Czempiel, Egon Burian, Marcus R Makowski, Rickmer Braren, Nassir Navab, Thomas Wendler

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matthias Keicher *Computer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany. matthias.keicher@tum.de.
Hendrik Burwinkel *Computer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany.
David Bani-Harouni *Computer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany.
Magdalini PaschaliComputer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany.
Tobias CzempielComputer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany.
Egon BurianDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.
Marcus R MakowskiDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.
Rickmer BrarenDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.
Nassir NavabComputer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany.
Thomas WendlerComputer Aided Medical Procedures and Augmented Reality, School of Computation, Information and Technology, Technical University of Munich, Boltzmannstr. 3, 85748, Garching, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When dealing with a newly emerging disease such as COVID-19, the impact of patient- and disease-specific factors (e.g., body weight or known co-morbidities) on the immediate course of the disease is largely unknown. An accurate prediction of the most likely individual disease progression can improve the planning of limited resources and finding the optimal treatment for patients. In the case of COVID-19, the need for intensive care unit (ICU) admission of pneumonia patients can often only be determined on short notice by acute indicators such as vital signs (e.g., breathing rate, blood oxygen levels), whereas statistical analysis and decision support systems that integrate all of the available data could enable an earlier prognosis. To this end, we propose a holistic, multimodal graph-based approach combining imaging and non-imaging information. Specifically, we introduce a multimodal similarity metric to build a population graph that shows a clustering of patients. For each patient in the graph, we extract radiomic features from a segmentation network that also serves as a latent image feature encoder. Together with clinical patient data like vital signs, demographics, and lab results, these modalities are combined into a multimodal representation of each patient. This feature extraction is trained end-to-end with an image-based Graph Attention Network to process the population graph and predict the COVID-19 patient outcomes: admission to ICU, need for ventilation, and mortality. To combine multiple modalities, radiomic features are extracted from chest CTs using a segmentation neural network. Results on a dataset collected in Klinikum rechts der Isar in Munich, Germany and the publicly available iCTCF dataset show that our approach outperforms single modality and non-graph baselines. Moreover, our clustering and graph attention increases understanding of the patient relationships within the population graph and provides insight into the network's decision-making process.

Indexed as

COVID-19Disease ProgressionHospitalizationHumansLungPrognosis

Identifiers

PMID37945590
PMCPMC10636061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.